gantenerumab (RG1450) - Roche, MorphoSys
|
crenezumab (MABT5102A) - Roche
|
umibecestat (CNP520) - Novartis, Amgen, Banner Alzheimer’s Institute
|
lanabecestat (AZD3293) - AstraZeneca, Eli Lilly
|
atabecestat (JNJ-54861911) - J&J
|
elenbecestat (E2609) - Eisai, Biogen
|
solanezumab (LY2062430) - Eli Lilly
|
bapineuzumab (AAB-001) - Pfizer, J&J, Perrigo Company
|
verubecestat (MK-8931) - Merck (MSD)
|